Then, based on IPF's differentially expressed genes, a network analysis was conducted to discover JHF's therapeutic targets that might target IPF's differentially expressed genes, their biological functions, and the important pathways involved in this response. This evidence concerns the gene ANTXR2 and idiopathic pulmonary fibrosis.